Skip to content

Harm-reduction information only — not medical advice. In crisis or experiencing adverse effects, contact a healthcare professional or your local emergency services immediately.

AnabolicDex logo AnabolicDex
Search (no-JS fallback)

Test E + Masteron Cutting (12 weeks)

Cutting cycle: 300mg/wk Test E + 400mg/wk Masteron Enanthate (drostanolone). Masteron provides a hardening effect and anti-estrogenic activity.

Concentration over time

Concentration values over time. Rows are sampled dates; columns are compounds.
DateMasteron EnanthateTestosterone Enanthate
W10.000.00
W11217.36997.75
W22075.011540.58
W32477.751817.53
W42639.261957.03
W52961.822024.72
W63113.622053.94
W73160.852061.54
W83143.852055.81
W93087.602040.62
W103007.782017.53
W112914.331986.83
W121948.07

Protocol summary

Test E + Masteron Cutting (12 weeks) · 12 weeks starting Jul 20, 26

  • Testosterone Enanthate — 150.0 mg 2×/week (Mon/Thu), weeks 0–12
  • Masteron Enanthate — 200.0 mg 2×/week (Mon/Thu), weeks 0–12

Protocol overview

Category
cutting
Duration
12 weeks
Compounds
2
Tags
cutting, masteron, drostanolone, hardening

Compounds in this protocol

How to read this protocol

The chart above shows the modeled blood concentration of each compound over the 12-week duration. Each compound accumulates toward steady state (roughly 5 half-lives). The peak-to-trough ratio within each dose interval depends on the injection frequency relative to the half-life.

Use the [peak-trough estimator](/tools/peak-trough) to see predicted levels at any point, or the [clearance calculator](/tools/clearance) to estimate washout after the protocol ends. The [PCT planner](/pct-planner) estimates when to start post-cycle therapy.

Educational only. Not medical advice. Concentration values are modeled estimates based on population pharmacokinetics, not predictions of individual blood levels.